Mira Pharmaceuticals (MIRA) Gains from Investment Securities (2022 - 2025)

Mira Pharmaceuticals has disclosed Gains from Investment Securities across 4 years of filings, most recently posting $100000.0 for Q4 2025.

• Gains from Investment Securities for Q4 2025 came in at $100000.0, down 97.64% year-over-year; the trailing twelve-month figure through Dec 2025 was $100000.0 (down 97.64% YoY), and the FY2025 annual result was $100000.0, down 97.64% from the prior year.
• Gains from Investment Securities came in at $100000.0 for Q4 2025 at Mira Pharmaceuticals, up from $75000.0 in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $4.2 million in Q4 2024 to a low of $33332.0 in Q1 2025.
• The 4-year median for Gains from Investment Securities is $680000.5 (2023), against an average of $1.2 million.
• Peak annual rise in Gains from Investment Securities reached 884.92% in 2025, while the deepest fall reached 97.64% in 2025.
• Mira Pharmaceuticals' Gains from Investment Securities stood at $750000.0 in 2022, then jumped by 62.0% to $1.2 million in 2023, then jumped by 248.61% to $4.2 million in 2024, then plunged by 97.64% to $100000.0 in 2025.
• The last three Gains from Investment Securities figures came in at $100000.0 (Q4 2025), $75000.0 (Q3 2025), and $4.2 million (Q2 2025), per Business Quant data.